3 months Premium FREE
No credit card. No commitment.
Becton Dickinson and Company
🇺🇸 BDX · NYSE/NASDAQ · US0758871091
Healthcare
Scores
Key Metrics
Powered by EODHDP/E (TTM)
57.2
P/E (Price-to-Earnings)Shows how much investors pay for each $1 of profit. We display the TTM P/E (Trailing Twelve Months) which uses actual earnings from the last 4 quarters. This is more reliable than Forward P/E which uses analyst estimates.
Net Debt/EBITDA (TTM)
4.1x
Latest quarter: 23.5x
Net Debt / EBITDAA leverage ratio showing how many years of EBITDA (earnings before interest, taxes, depreciation, and amortization) it would take to repay net debt. EBITDA approximates operating cash generation. Lower ratios (e.g., <3x) are generally safer; higher (e.g., >5x) may indicate more financial risk.
Latest quarter (2026-06-30): 23.5x
The quarterly value can spike when quarterly EBITDA is very low (e.g., one-time charges).
Quick guide: <2x manageable, >4x can be risky (sector-dependent).
ROE
6.6%
ROE (Return on Equity)A profitability measure: how much profit is generated from shareholders’ equity. Higher isn’t always better if it comes from high debt.
EV/EBITDA
13.7x
EV/EBITDAA valuation ratio that compares total business value (including debt) to EBITDA. Lower can mean cheaper, but context matters.
Dividend Summary
Powered by EODHDDividend Yield (Fwd)
2.60%
TTM: 1.97%
Dividend YieldThe Forward yield (Fwd) shows the next announced annual dividend / current price — what you'd earn going forward. The Trailing yield (TTM) in the tooltip shows dividends actually paid in the last 12 months. Forward is shown as primary because it reflects the company's current commitment to shareholders.
Forward Yield (estimated): 2.60%
Trailing Yield (TTM, last 12 months): 1.97%
Payout Ratio (Fwd)
30.6% TTM
Payout RatioDividends as a percentage of earnings. The Forward payout (Fwd) uses the announced dividend divided by actual past earnings (TTM) — it tells you if the company can afford what it promised. Very high payouts can be risky, especially if profits fall.
Announced dividend / actual earnings (TTM)
Dividend History
EODHD Dividends API| Status | Type | Decl. Date | Ex-Div Date | Pay Date | Currency | Amount |
|---|---|---|---|---|---|---|
| Forecast* | Quarterly | — | 09 Jun 2027 | — | USD | 1.05 |
| Forecast* | Quarterly | — | 10 Mar 2027 | — | USD | 1.05 |
| Forecast* | Quarterly | — | 08 Dec 2026 | — | USD | 0.8255 |
| Declared | Quarterly | 28 Jul 2026 | 09 Sep 2026 | 30 Sep 2026 | USD | 1.05 |
| Paid | Quarterly | 28 Apr 2026 | 09 Jun 2026 | 30 Jun 2026 | USD | 1.05 |
| Paid | Quarterly | 27 Jan 2026 | 10 Mar 2026 | 31 Mar 2026 | USD | 1.05 |
| Paid | Quarterly | 06 Nov 2025 | 08 Dec 2025 | 31 Dec 2025 | USD | 0.8255 |
| Paid | Quarterly | 22 Jul 2025 | 08 Sep 2025 | 30 Sep 2025 | USD | 0.8176 |
* Extrapolated from past dividend history. Not an official announcement — treat as an estimate, not a confirmed date or amount.
Summary
Becton Dickinson is an entrenched medical technology leader generating massive free cash flow, underscored by a recently declared 21.3% dividend raise and robust buybacks. While one-time spin-off charges have created a temporary GAAP earnings depression, the underlying business remains highly resilient despite elevated leverage and structural litigation overhangs. Existing holders should maintain positions, though new capital may want to wait for a more compelling valuation or higher absolute yield.
Sector Context
Becton Dickinson operates in the essential healthcare supplies and medical devices industry. This sector provides highly predictable, recession-resistant cash flows ideal for dividend growth, though it frequently carries structural risks related to intense FDA regulations, mass tort litigation, and environmental compliance.
Temporary Opportunity Identified
The recent quarter's $311 million net loss was driven entirely by one-time integration costs, non-cash asset impairments, and charges related to the Biosciences spin-off, masking underlying revenue growth of 5.2%.
📊 Strategy Analysis
- • Recently declared a substantial 21.3% upcoming dividend raise (to $3.98), reflecting strong management confidence in future cash flows.
- • Healthy Free Cash Flow coverage of 1.48x, with the business generating $5.09B in FCF to comfortably sustain the 52.8% cash payout.
- • Strong capital return program featuring a net buyback yield of 4.79%, pushing the total shareholder yield to an impressive 7.02%.
⚠ What to Watch
- • Net Debt/EBITDA remains elevated at 4.13x, exceeding conservative 3.0x thresholds and limiting balance sheet flexibility.
- • Major structural liabilities persist, including a $1.9 billion hernia mesh litigation reserve and ongoing capital requirements for strict EPA EtO compliance.
- • The forward dividend yield of 2.09% is relatively low for strict income-oriented DGI portfolios, and TTM P/E sits extremely high at 57.19x due to GAAP distortions.
📊 Historical Trends (10 Years)
Powered by EODHDThese charts show how key metrics have evolved over the past decade, helping you identify if the company is improving or deteriorating.
Debt Evolution (Net Debt / EBITDA)
Lower values are better. A declining trend indicates the company is reducing its debt (deleveraging).
Revenue & Earnings Growth
Consistent growth in revenueRevenue
The money a company brings in from selling its products or services. It’s the top line before costs. (blue) and earningsEarnings (Profit)
What’s left after expenses. Positive earnings mean the business made a profit; negative means a loss. (green) indicates a healthy business. Look for upward trends and recoveries after temporary dips.
Dividend Sustainability (FCF vs Dividends Paid)
Free cash flowFree Cash Flow
Cash left after the company pays for running the business and maintaining it. Often used to fund dividends, pay debt, or buy back shares. (FCFFCF (Free Cash Flow)
Short for Free Cash Flow: cash left after operating needs and maintenance spending., blue) should cover dividends paidDividends Paid
Cash the company paid out to shareholders. It’s not guaranteed and can change over time. (green). If dividends consistently exceed FCFFCF (Free Cash Flow)
Short for Free Cash Flow: cash left after operating needs and maintenance spending., the dividend may be at risk.
Analysis date: 2026-08-22
Disclaimer: This information is for educational purposes only. Not financial advice.